Between smaller portions, fewer snacks, and a reduced appetite overall, some people may consume less sodium than they did before starting treatment
Rethinking Risk Thresholds in Diabetes Care May 12, 2026 Articles, Diabetes, GLP- 1 Agonist Therapy Center, GLP-1 Agonist Therapy Center, Obesity, Therapies, Type 2 Diabetes, Type 2 Diabetes 1,139 views A patient loses 30 pounds, lowers their A1C, and improves their blood pressure within months of starting a GLP-1 medication
This is such a great initiative supporting healthy weight loss during aging while protecting strength and independence is exactly the kind of thoughtful care seniors need
Ozempic and other glucagon-like peptide-1 (GLP-1) receptor analogs, such as Wegovy, are drugs that mimic fullness hormone GLP-1 and have been shown to reduce appetite, slow digestion, help stabilize blood sugar levels and impact metabolism
10.1111/j.2040-1124.2010.00022.x 159 ShaikhS.RizviS